Materials and methods for inhibiting cancer cell invasion related to FGFR4

Details for Australian Patent Application No. 2009289136 (hide)

Owner Licentia Ltd.

Inventors Alitalo, Kari; Lehti, Kaisa; Keski-Oja, Jorma; Alitalo, Annamari

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2009289136

PCT Pub. Number WO2010/026291

Priority 61/093,925 03.09.08 US; 61/156,634 02.03.09 US

Filing date 2 September 2009

Wipo publication date 11 March 2010

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 38/10 (2006.01) Medicinal preparations containing peptides - Peptides having 12 to 20 amino acids

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

C12N 5/20 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - one of the fusion partners being a B lymphocyte

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

Event Publications

28 April 2011 PCT application entered the National Phase

  PCT publication WO2010/026291 Priority application(s): WO2010/026291

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009289174-Temporary embolic protection device and medical procedure for delivery thereof

2009289124-Thermally emissive apparatus